iiict;~I>oli\~ir di\ordcr\ in the p;tthogenc\ir of \colio\i\ (in Ru\\i;ilr). Ortop. Tr;ivrn;~tol. I'rotcr (hlo\Lv;i). . ?-7: 8 7 ( 197 1 Illootl v o l u~~~e , p l a s~~~:~ v o l u~~~c ant1 recl cell Illass, recl cell p a r a~~~e t e r s , rctic~~locjtes, serunl iron. ant1 total iron I)ir~tling capacity were ir~vcstig:~tecl. I7iftj-r~inc gro\\tl~-rcf;~rclctl cl~ilclren Itere stutlietl: 27 c l~i l t l r e~~ \$it11 itliopathic sl~ort st:~turc (ISS) ancl 3 2 cl~ilclren wit11 isolatecl growtl~ h o r r~~o r~e cleficie~~cy (GIII)). I;ifteer~ of the (;Ill) ~) :~t i c~~t s were st~~cliecl I~efore t r e a t~~~r~~t ant1 again 3-6 111ol11l1s after or~sct o f t r c a t r~~c~~t wit11 gro\\ll~ 11or111or1e. 3 -G I I I ) patients only Ijefore ;~ncl 1 1 only clurir~g f r e a t~~~c~~t . Illoocl v o l u~~~e , p l a s~~~:~ volun~e, ;~r~cl recl cell Illass \\ere significantly ( P < 0.005) clecreasetl I)y 15% in the ul~trcatecl <;III)
patic.111~ i~ntl u e r e 11or111:11 in t l~e cl~ilclre~~ stucliecl (Inring treat-I I I~I I~ wit11 gro\rtl~ I~o r r~~o n c cor~~parecl \ritl~ tlre values in ISS patients. In t l~e 1 5 GIII) patients stucliccl before ant1 (luring t r e a t~~~e r~t , I)lootl ~O~I I I I I~, ,,I~SIII;I v o l u r~~e , ancl recl cell mass ir~creasetl by 17% to r~o r n~a l values ( P < 0.0005) on trcatlllerlt wit11 growtl~ I I O~I I I O I I~. S o significant tliffere~~ces were ( I~I I I~I Istr;~l)lc between values relatecl to actual I)ocly ~r e i g l~t ;111cl to correctetl ~veigl~t for I~eigl~t. I l e~~~a t o c r i t , llleorl corpuscr~l;~r vol-I I I I I~. ancl reticuloc~tes rer~~ainccl u~~c l~a~~g c c l .
Scrl1111 iron ant1
iron i~~creasetl a h total iron 1)intling capacity clecreasctl signifirantly cluri~~g grow111 11or111one s~rl)stitutior~. 111 a 1);rir of t\rir~s wit11 Russell-Silver clbvarfis~~~ ant1 GIID, grot~tli I~o r n~o n e incrcasecl I~loocl ~~I I I I I I~, p l a s l~~a v o l u r~~c , ant1 rccl ccll Illass as in the other Gl11) patients. 111 another pair of ttrins with HusseIISilver t l w a r f i s~~~ witl~out GIII), growth the I I O~I I I O I I~ was \rithout cffrrt on I)loocl Y O~I I I I I~.
Our results of clecrcasecl bloocl v o l u r~~e and rccl cell Illass in clrilclrel~ with isolatccl GIII) ant1 t l~c incre:~se of I~loocl v o l u r~~c ant1 recl cell Illass tluring grontll h o r n~o n e t r e a t~~~e l~t provicle clirect eviclence that growth Iiorn~one is s t i~~~u l a t i~~g e r j thropoicsis. T l~c less pronouncecl tlccreasc of blootl v o l u~~~c ancl recl ccll III;ISS in our patients c o~~~p a r c c l wit11 t l~c literatore data ol)tair~ecl or1 par~l~>l)opituitary ancl I~jpopl~jsector~~izetl s111)jccts niay ir~cli-cate that growth h o r l~~o n e , tlijrosin, and other I~o r n~o n e s :let synergistically on erjtl~ropoicsis.
111 cliiltlren nitti patill? ~)opituitaris~ii o r isolatecl GIII), 1)loocl volunic, plasn~a volunie, ant1 retl cell niass were founcl to be clecrcasetl by apl)rosiniately 30% 1)elotv ~iornial ( 2 8 . 3 0 ) . .l'l~ere-fore. Shal~icli ant1 conorkers (30) reconinicnclecl checking of blood v o l u n~e in orcler to tlistinguisli 1)et~recn tl\varfisni tluc to p a~i l i >~) o l ) i t i~i t a r i s~~i o r GIII) ant1 itliol~athic short stature. 'l'lieir rep)cts, lio\rcvcr, inclucle only one 1)afient ~ritli isolatccl GIII) (ZX), o r (lo not tliffcrentiate bet\rcen chilclrc~i rritli isolatctl G I 11) aricl p a n l i~ popituitarisn (30). 'l'lic effect of gro\r tli Iior~n o n e on blootl v o l u n~c in isolatetl G l I D lias not yet 1)ec.n stucliccl.
t-iftccn paticnts \\it11 GI 11). including one pair of t\\ins \\it11 Iiusscll-Silver il\varfism. \Yere stuilictl bcforc treatment a~iil again 3-6 monrlls aftcr onset of trciitriicnt \\it11 liu~ii;~ri gro\vtli hormone ( 1 0 IU/mS/\\cck). In addition. 3 GI 11) p;~ticnts hefore trcatmcnt. arid 14 during treatment \\,ere es:~minctl. 'l'hc control group compriscil 77 cliilrlrcn \vith icliopathic short st;~turc. I-r~r-thcrriiore. another pair of t\\ins \\.it11 liusscll-Silver il\varfism hut \\.ithout GIII) \\as studiecl beforc ariil ilurilig treatment \\it11 gro\\th liorriioric. N o furrllcr trc;rtmcnt \\.:is pcrforriicd. Infornicil consent \\.:IS ohtailictl from patients i~ntllor parcrits in every ciisc before investigation \\:IS st;~rtcil. Since childrcri \\it11 liypopituitarim are often ovcr\\ciglit for heiglit (17) . \\e obtairieil tlic ";rppr~pri;~tc" (corrected) \\eight for the ;ictu:rl liciglit from nomogralns (2 1). The age tlistrih~rtion \\as siniilar ill all groups (5-18 yc;rrs). 'l'hc c~iclocriric stuilies pcrformetl in all cliilclrcn inclutlc~l ilctcrrnination of gro\\th hormone (in\ulin tolerarice test). th!rosin. cortisol. ant1 goriaclotropiris b!, st;iridarcl proccclurcs (ra~lioimmurio:~ss:~ys). ~I'lic cliilclrcn \\.it11 ISS \vcrc \\ithotit cndocrirlc ;thnormalities anel the p;~tients wit11 G I 111 \\ere \\itliout further c~idocrine ahnornlalitics. A possihlc gonadotrophic ilcficicnc!, cannot be ruled out iri prcl~rhertal cliililrcn.
Ilcmatocrit was measurctl hy the ~iiicrohcrii;itc~crit mctliorl lisirig a correction factor of 0.OS for trapped p l a s~n :~ ( 2 3 ) . I<ctic-ulocytcs were c o u n t c~l aftcr sti~ining \ \ i l l 1 hrilliarit crcsyl Illuc. Serum iron and total irori-hi~iiling c;~pacity (TIBC) \\ere iletcrmincil hy the use of sulfonatcrl hatliol>lienantlirolinc. I'lasma volumc \\.;is mc:~surcd I ? ! mean.; o f I1v:lns Illue ll>.c i11jcc.tc.d in iloscs of 0.2 mg/kg. Details of the riictliotl ernplo!.etl arc tlcscribed clsc\vhcrc ( 7 7 ) . '1'11~ ~(~s t r i l i x hlooil siiniplc was taken 10 min :~ftcr injection o f the il!c. In I 0 p;~ticnts the clis;~ppcar;r~ic.c. rate of Evans blue \vas estini;itcil h!, taking four to six hlood samples \vitliiri 1 lir after injection of the dye. 'l'licsc stuilics revealed : I mean crror of + I .O t ?.(I!'; (SI)) hy il!c ~1isappc;rrancc if only one hlood s;~rilplc tvas taken 10 min aftcr tlic injection of the d!c. Bloc~tl volumc ant1 reti mass \\.ere calculatccl from pl;rsma volunlc anti Iicniatocrit using a I>otly/ venous Iic11i;itocrit ratio of 0.0 l (7. 1 0 ) . This mctliotl c;~trscs sigriificant crror if the hocly/vcnous 11cm;rtocrit ratio is markedly different from 0 . 0 1 . Blootl volurnc ilctcrmination by tloul>lc isotope tccliriitl~rcs ill chiltlrcn suffering from Ii!l>opituitarism (28) sl~o\vctl : I ~iic:irl l>oiIy/\~crio~rs 1ic1ii:rtocrit ratio of 0.00 5 0.07 (Sf)) if the reported hematocrits \\ere corrcctcil for trappCil plasm;^. 'l'liercforc. our mctlioil secliis to he ailccluate ant1 h;is the aclvantagc of prc\,cnting the lia~arils of r;iili:~tion csposurc.
7'hc inilividual il;ita of hlooil volumc anti red cell niass per kg body weight arc slio\vn in 1:igurc 1 . In reference 10 corrcctccl \\eight for liciglit llic valucs of tllc GI111 p;~ticrits \\,ere sliglltly higher. Ncvertliclcss. hloocl volume. pl;rsma volume. ;inel rctl cell mass relatctl to both actual boil!, \\eight anil corrcctcil \\eiglit for liciglit \\ere sigriificantly lo\vcr (I' < 0.005) in thc untrc;rtcrl cliildrcn \\.it11 GI 11) in compi~rison to the cliilclrcn \villi idiop;~tliic short st;iturc (T;rl>lc I ).
In any of the paticnts studicil t\\icc. hlood vc~luriic. plasrn;~ volurlic. ant1 rctl cell mass incrcasctl tluring treatment \\it11 gro\\tli Iiorriio~ic (Fig. 1 ) . I~'~~rtlicrrliorc. scrurii iron ilccrcascil i11it1 'I'II3C incrc;iscil signific;r~itly during 1re;Itment. \\llcrc;is hcmatocrit. mcari corpuscular volume (XIC'V). :11it1 rcticulocytcs rcniairicil ~~ncli;~rlgerl (Tahlc 2). T\vo p;~irs of [\\ins \\it11 RusscllSilver il\varfism \\ere stucliecl I>cforc. ;~n d 3-6 months aftcr the iriitiatio~i of gro\vth Ilornionc therapy (Fig. 3 ) . O n e of the pairs \\;is \\itllout endocrine ahnorrnalitics: tllc other pair hacl GI 11). nloocl volume. ~I ; I \ I~: I volun~c. ;inil 1 .~1 1 cell n);ls\ i~~c.rc:~\ccl o11Iy in the twins \\.it11 CillI) (luring treatment.
~I'lic prcsc~it stut1y proviclcs cviilcncc 1li:it the total Illood vc~lunlc is rctlucc~l hy approsimatcly 15!i helo\\. norrn;~l v;rluc\ in cliiltlren \\it11 isolated GI l l 1 hccausc of ;In eilual rcductio~l of plasm;^ volumc as \\ell as of red cell m;iss. 'l'lic cffcct of pituit;~ry deficiency o n plasm;^ volumc ;1n~1 rcil cell Inass lias heen st~rtlieil estcrisivcly hy several autliors in hypopliysccto~iiizcil anim;~ls. In hylx~l>liyaccto~iii~cil rats. rcil cell nl;iss is dccrcascil by ;ihout 407;. \\hereas plasni;~ volunic is nor1n;il o r only slightly ilc-. cre;~scil. resulting in a marLctl pcriplicr;~l :inerni;r (1. 7. 5 . 1 1 . 12. 10. 2 4 . 2 9 ) . In clogs ant1 monke!~. liypophysccto~i~y clocs riot change licmatocrit Ilut reiluccs pl;~sm;r volume arid reel cell mas\: in riionkcys hy 30!i ( 2 s . 32) and in clogs by 407; (4). Fc\v similar stutlics o n hlood volu~iic have hccrl clone in the pituitarytlcficicnt human. I lypopli!scctoriiy in ;~dult paticnts results in : I p;irallcl ilccrcasc of plirsma volumc aricl red cell niass by :tho~lt 40!; ( 14) and in cliililren \\it11 panhypopit~rit:~risrii I>y 30C;. (28).
In a recent sturly of a group of I 0 children suffcrilig fro111 panhyl~ol>ituit;irisrii o r isol;itcil CiI 11) a rctluction of plasm:i volume ant1 red cell 111;rss by ahout 305; was slio\vn ( 3 0 ) . I'hc ldoorl volumc v;~lucs in any of these patients \\ere llclo\v the range of cliiltlrcn \\it11 short st;iturc \vitIiout endocrine abnorm:~lities. 7'hc authors concluilctl that the tlctcrmination of rctl cell mass anil plasma volumc may he of tliscrirniniitirig v;~luc iri cliilclrcri \\it11 short stature. I1o\\cvcr. i l l colitr;~st to tliis 1 1 i i~c~I group. our pliticnts \\it11 isolatcil Gl11) sho\vccl less pronoirnccd volumc In the human the comhinccl trc;1tlncrlt \\it11 t l~y r o s i~i . aclrcn;~l stcroicls. gro\vth Ilornlonc. a n d tchtostcronc norm;~lizcs rcil cell mass ancl increases plasma volume I>y IO?; :il?ovc normal in ~~a n l i y p o p i t u i t~~r i s r i i (20) . 'l'lie influcncc of grot\ 111 hor111o11c 011 I>Iood volur~le h;rs 1101 ) e t I~c e n stuclictl i l l chilclrcrl u i t h isolated Gl11). O u r results sho\v t h ;~t in chiltlrcn \\.it11 G I 11) :~clministr:~tion of gro\\th h o r m o n e nornlalizcs to1;rl I>lood volume. pla\ma volume, anil reel cell nlass. In the trio patients n i t h I<irsscll-Silver d\\arfi\rn n i t h o u t G I 11). (9) . a n d t h e r e f o r e were n o r m a l i n o u r p a t i e n t s studied 3-5 m o n t h s a f t c r onset of treatment. 
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